Antonio Di Muzio

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)

B. Castagneto, Mario Botta, Enrico Aitini et al. · Annals of Oncology · 2007 · 139 citations · Full text

Medicine, Oncology, Pharmacology +13

Large scale genotype–phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy

Giulia Ricci, Isabella Scionti, Francesco Sera et al. · Brain · 2013 · 126 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Large-Scale Population Analysis Challenges the Current Criteria for the Molecular Diagnosis of Fascioscapulohumeral Muscular Dystrophy

Isabella Scionti, Francesca Gabriella Greco, Giulia Ricci et al. · The American Journal of Human Genetics · 2012 · 124 citations · Full text

Medicine, Genetics, Molecular Biology +14

Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA)

Valentina Gatta, Oronzo Scarciolla, Anna Rita Gaspari et al. · Human Genetics · 2005 · 113 citations

Life Sciences, Genetics, Molecular Genetics +9